AMYLOIDOSIS, HEREDITARY

Clinical trials for AMYLOIDOSIS, HEREDITARY explained in plain language.

Never miss a new study

Get alerted when new AMYLOIDOSIS, HEREDITARY trials appear

Sign up with your email to follow new studies for AMYLOIDOSIS, HEREDITARY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 3 Not yet recruiting 1 Not yet finished but already full! 1 Completed 1

Heart check: do Nerve-Targeting drugs also shield the heart in rare amyloidosis?

Knowledge-focused Ongoing

This study follows 20 adults with hereditary transthyretin amyloidosis (ATTRv) who have both nerve and heart involvement. They are treated with patisiran or vutrisiran for two years. Researchers use MRI scans and questionnaires to see how the drugs affect heart structure and func…

Matched conditions: AMYLOIDOSIS, HEREDITARY

Sponsor: Rennes University Hospital • Aim: Knowledge-focused

Last updated Jun 27, 2026 08:08 UTC

AMYLOIDOSIS, HEREDITARY

Get alerted when new AMYLOIDOSIS, HEREDITARY trials appear

Heart check: do Nerve-Targeting drugs also shield the heart in rare amyloidosis?